培训课件-乳腺癌中山大学肿瘤医院20101019.pptVIP

Data from the Early Breast Cancer Trialists’ Collaborative Group meta-analysis has shown that tamoxifen reduces the risk of recurrence and improves survival in patients with ER-positive or ER-unknown early stage breast cancer. Cytotoxic chemotherapy has also been demonstrated to confer benefit, but has a greater impact for younger patients compared with older patients. Combined treatment with both endocrine therapy and chemotherapy is additive in terms of reducing the risk of recurrence and improving survival. Parathyroid hormone related peptide PTHrP is a protein produced by tumours wh